Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic

J Cardiol. 2022 Apr;79(4):455-459. doi: 10.1016/j.jjcc.2021.08.006. Epub 2021 Aug 19.

Abstract

Coronavirus disease-2019 (COVID-19) has a profound impact on the health care system worldwide. In the COVID-19 pandemic, hospitals are required to halt elective surgeries and procedures for preventing nosocomial infections and saving medical resources. In these situations, emergency procedures are required for life-threatening cardiovascular diseases such as acute coronary syndrome and cardiogenic shock. To prevent the spread of COVID-19, a social distance is essentially required. In ordinary percutaneous coronary intervention (PCI), operators manipulate the devices standing at the patient's tableside during the whole procedure, which may involve a certain risk of exposure to patients with COVID-19. A robotic-assisted PCI (R-PCI) allows operators to manipulate devices remotely, sitting at a cockpit located several meters away from the patient, and in addition, the assistant can be at the foot of the bed, much further from the access site. R-PCI can help to minimize the radiation exposure and the amount of person-to-person contact, and consequently may reduce the risk for the exposure to the virus.

Keywords: Acute coronary syndrome; COVID-19; Percutaneous coronary intervention; Robotic-assisted procedures.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Coronary Angiography
  • Coronary Artery Disease* / surgery
  • Humans
  • Pandemics
  • Percutaneous Coronary Intervention* / adverse effects
  • Robotic Surgical Procedures*
  • SARS-CoV-2
  • Treatment Outcome